KalVista Pharmaceuticals, Inc. (KALV)
20.48
+0.92
(+4.70%)
USD |
NASDAQ |
Apr 17, 14:52
KalVista Pharmaceuticals EPS Diluted (Quarterly) : -0.1055 for Dec. 31, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Intellia Therapeutics, Inc. | -0.8263 |
| Recursion Pharmaceuticals, Inc. | -0.2053 |
| Tango Therapeutics, Inc. | -0.2945 |
| Modular Medical, Inc. | -3.349 |
| Iovance Biotherapeutics, Inc. | -0.1767 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -5.372M |
| Revenue (Quarterly) | 59.92M |
| Total Expenses (Quarterly) | 65.30M |
| Enterprise Value | 985.91M |
| Gross Profit Margin (Quarterly) | 93.36% |
| Profit Margin (Quarterly) | -8.96% |
| Earnings Yield | -15.61% |
| Normalized Earnings Yield | -15.38 |